Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers — Siemens Healthcare Diagnostics (PMA P000021)
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers — Siemens Healthcare Diagnostics (PMA P000021) is one of 9,000 device clearances in the DeviceClear dataset. Key details — Device name: Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers; Applicant: Siemens Healthcare Diagnostics; Cleara
| Device name | Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers |
|---|---|
| Applicant | Siemens Healthcare Diagnostics |
| Clearance track | PMA |
| Submission number | P000021 |
| Decision | APPR |
| Decision date | 2018-04-13 |
| Date received | 2017-09-25 |
| Product code | LTJ |
| Device class | 2 |
| Medical specialty | Immunology |
| Applicant location | DE |
| Source | openFDA device |
🔍 Search all device clearances →
$1999/mo
Try DeviceClear →